234 related articles for article (PubMed ID: 32753245)
21. [Angioedema and anaphylaxis, a family story].
Martinet C; Gherri N; Laborde L; Gil-Jardine C; Chauvin A; Lefort H
Rev Infirm; 2022; 71(282):27-29. PubMed ID: 36150835
[TBL] [Abstract][Full Text] [Related]
22. Novelties in the Diagnosis and Treatment of Angioedema.
Cicardi M; Suffritti C; Perego F; Caccia S
J Investig Allergol Clin Immunol; 2016; 26(4):212-21; quiz two pages after page 221. PubMed ID: 27470642
[TBL] [Abstract][Full Text] [Related]
23. Hereditary angioedema with normal C1 inhibitor.
Bork K
Immunol Allergy Clin North Am; 2013 Nov; 33(4):457-70. PubMed ID: 24176211
[TBL] [Abstract][Full Text] [Related]
24. [Hereditary and acquired angioedema: clinical characteristics in 8 patients and review of the literature].
Fonseca Aizpuru EM; Rodríguez Avila EE; Arias Miranda I; Nuño Mateo FJ
Rev Clin Esp; 2009; 209(7):332-6. PubMed ID: 19709536
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G; Nguyen Y; Amarger S; Aubineau M; Bibes B; Blanchard-Delaunay C; Boccon-Gibod I; Bouillet L; Coppo P; Dalmas MC; Debord-Peguet S; Defendi F; Demoreuil C; Du-Thanh A; Gayet S; Hadjadj J; Jeandel PY; Launay D; Ly KH; Avoy CM; Niault M; Ollivier Y; Pelletier F; Porneuf M; Roos-Weil D; Fain O; Gobert D
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):212-222. PubMed ID: 37844846
[TBL] [Abstract][Full Text] [Related]
26. Biological therapy in hereditary angioedema: transformation of a rare disease.
Longhurst H; Farkas H
Expert Opin Biol Ther; 2020 May; 20(5):493-501. PubMed ID: 31994957
[No Abstract] [Full Text] [Related]
27. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
Stehlin F; Ribi C
Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
[TBL] [Abstract][Full Text] [Related]
28. "Nuts and Bolts" of Laboratory Evaluation of Angioedema.
Farkas H; Veszeli N; Kajdácsi E; Cervenak L; Varga L
Clin Rev Allergy Immunol; 2016 Oct; 51(2):140-51. PubMed ID: 27142368
[TBL] [Abstract][Full Text] [Related]
29. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship.
Castelli R; Zanichelli A; Cicardi M; Cugno M
Crit Rev Oncol Hematol; 2013 Sep; 87(3):323-32. PubMed ID: 23490322
[TBL] [Abstract][Full Text] [Related]
30. [Practical management of C1 inhibitor deficiency].
Pedraz J; Daudén E; García-Diez A
Actas Dermosifiliogr; 2007 May; 98(4):240-9. PubMed ID: 17506955
[TBL] [Abstract][Full Text] [Related]
31. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
Prescrire Int; 2010 Nov; 19(110):245-7. PubMed ID: 21284353
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
Zanichelli A; Mansi M; Periti G; Cicardi M
Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
[TBL] [Abstract][Full Text] [Related]
33. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
Kawalec P; Holko P; Paszulewicz A; Obtułowicz K
Pneumonol Alergol Pol; 2013; 81(2):95-104. PubMed ID: 23420425
[TBL] [Abstract][Full Text] [Related]
34. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
Wu MA; Castelli R
Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
[TBL] [Abstract][Full Text] [Related]
35. Genetic Determinants of C1 Inhibitor Deficiency Angioedema Age of Onset.
Gianni P; Loules G; Zamanakou M; Kompoti M; Csuka D; Psarros F; Magerl M; Moldovan D; Maurer M; Speletas MG; Farkas H; Germenis AE
Int Arch Allergy Immunol; 2017; 174(3-4):200-204. PubMed ID: 29130992
[TBL] [Abstract][Full Text] [Related]
36. Bradykinin-mediated angioedema: factors associated with admission to an intensive care unit, a multicenter study.
Javaud N; Floccard B; Gontier F; Lapostolle F; Boccon-Gibod I; Martin L; Amarger S; Boumedienne A; Boubaya M; Asfar P; Coppere B; Ollivier Y; Bouillet L; Adnet F; Fain O
Eur J Emerg Med; 2016 Jun; 23(3):219-23. PubMed ID: 25715023
[TBL] [Abstract][Full Text] [Related]
37. Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: An observational study.
Zanichelli A; Ghezzi M; Santicchia I; Vacchini R; Cicardi M; Sparaco A; Donati G; Ranìa V; Busa A
PLoS One; 2020; 15(3):e0230128. PubMed ID: 32163480
[TBL] [Abstract][Full Text] [Related]
38. Bradykinin-mediated angioedema.
Obtułowicz K
Pol Arch Med Wewn; 2016; 126(1-2):76-85. PubMed ID: 26842379
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
40. [Hereditary angioedema: treatment and educational therapeutic program].
Boccon-Gibod I
Presse Med; 2015 Jan; 44(1):78-88. PubMed ID: 25499251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
